Legacy Cancer Institute uterine cancer patient survival rates

 

The tables below show Legacy Cancer Institute patient survival rates as compared to 1,409 American College of Surgeons Commission on Cancer-accredited cancer programs. Data is from patients diagnosed between 2003 and 2005, the most recent available.

 

 

Overall survival rates

   Less than 1 year  1 year 2 years  3 years   4 years  5 years
 National average  100%  92.6%  87.0%  83.0%  79.7%  79.9%
 Legacy Cancer Institute  100%  96.5%  92.2%  86.5%  84.5%  82.6%
                           

Survival rates: Patients with Stage I uterine cancer

   5 years  4 years  3 years  2 years  1 year  Less than 1 year
 National average  87.7%  90.2%  92.5%  95.0%  97.6%  51.9%
 Legacy Cancer Institute  88.2%  88.2%  90.2%  95.2%  96.2%  73.4%

Survival rates: Patients with Stage III uterine cancer

   Less than 1 year 1 year  2 years  3 years  4 years  5 years 
National average   100.0% 85.6%  71.7%  62.3%  56.3%  51.9% 
Legacy Cancer Institute   100.0% 100.0%  90.1%  83.4%  80.1%  73.4% 

During this time period, Legacy did not have enough patients with Stage II or IV cancer to show meaningful survival data for these stages.